These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 27535387)

  • 21. Low-dose computed tomography screening for lung cancer: how strong is the evidence?
    Woolf SH; Harris RP; Campos-Outcalt D
    JAMA Intern Med; 2014 Dec; 174(12):2019-22. PubMed ID: 25317533
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessing the Generalizability of the National Lung Screening Trial: Comparison of Patients with Stage 1 Disease.
    Tanner NT; Dai L; Bade BC; Gebregziabher M; Silvestri GA
    Am J Respir Crit Care Med; 2017 Sep; 196(5):602-608. PubMed ID: 28722466
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lung cancer screening.
    Tanoue LT; Tanner NT; Gould MK; Silvestri GA
    Am J Respir Crit Care Med; 2015 Jan; 191(1):19-33. PubMed ID: 25369325
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The importance of lung cancer screening with low-dose computed tomography for Medicare beneficiaries.
    Wood DE
    JAMA Intern Med; 2014 Dec; 174(12):2016-8. PubMed ID: 25317992
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Smoking behaviors among patients receiving computed tomography for lung cancer screening. Systematic review in support of the U.S. preventive services task force.
    Slatore CG; Baumann C; Pappas M; Humphrey LL
    Ann Am Thorac Soc; 2014 May; 11(4):619-27. PubMed ID: 24701999
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Applying the National Lung Screening Trial eligibility criteria to the US population: what percent of the population and of incident lung cancers would be covered?
    Pinsky PF; Berg CD
    J Med Screen; 2012 Sep; 19(3):154-6. PubMed ID: 23060474
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Screening for lung cancer. Too many uncertainties, even for smokers.
    Prescrire Int; 2014 Jan; 23(145):19-23. PubMed ID: 24516909
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lung cancer screening overdiagnosis: reports of overdiagnosis in screening for lung cancer are grossly exaggerated.
    Mortani Barbosa EJ
    Acad Radiol; 2015 Aug; 22(8):976-82. PubMed ID: 25772581
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cumulative incidence of false-positive test results in lung cancer screening: a randomized trial.
    Croswell JM; Baker SG; Marcus PM; Clapp JD; Kramer BS
    Ann Intern Med; 2010 Apr; 152(8):505-12, W176-80. PubMed ID: 20404381
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low-dose computed tomography screening reduces lung cancer mortality.
    Ostrowski M; MarjaĊ„ski T; Rzyman W
    Adv Med Sci; 2018 Sep; 63(2):230-236. PubMed ID: 29425790
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Issues with implementing a high-quality lung cancer screening program.
    Mulshine JL; D'Amico TA
    CA Cancer J Clin; 2014; 64(5):352-63. PubMed ID: 24976072
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Screening for lung cancer: it works, but does it really work?
    Silvestri GA
    Ann Intern Med; 2011 Oct; 155(8):537-9. PubMed ID: 21893614
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lung Cancer Screening With Low-Dose CT in the United States.
    Eberth JM
    J Am Coll Radiol; 2015 Dec; 12(12 Pt B):1395-402. PubMed ID: 26614885
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low-dose computed tomography screening for lung cancer and pleural mesothelioma in an asbestos-exposed population: baseline results of a prospective, nonrandomized feasibility trial--an Alpe-adria Thoracic Oncology Multidisciplinary Group Study (ATOM 002).
    Fasola G; Belvedere O; Aita M; Zanin T; Follador A; Cassetti P; Meduri S; De Pangher V; Pignata G; Rosolen V; Barbone F; Grossi F
    Oncologist; 2007 Oct; 12(10):1215-24. PubMed ID: 17962615
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A meta-analysis: is low-dose computed tomography a superior method for risky lung cancers screening population?
    Fu C; Liu Z; Zhu F; Li S; Jiang L
    Clin Respir J; 2016 May; 10(3):333-41. PubMed ID: 25307063
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New evidence supporting lung cancer screening with low dose CT & surgical implications.
    Dezube AR; Jaklitsch MT
    Eur J Surg Oncol; 2020 Jun; 46(6):982-990. PubMed ID: 32113886
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Results of the national lung cancer screening trial: where are we now?
    Chudgar NP; Bucciarelli PR; Jeffries EM; Rizk NP; Park BJ; Adusumilli PS; Jones DR
    Thorac Surg Clin; 2015 May; 25(2):145-53. PubMed ID: 25901558
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low-dose CT for lung cancer screening: opportunities and challenges.
    Shen H
    Front Med; 2018 Feb; 12(1):116-121. PubMed ID: 29218678
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lung cancer screening with low-dose CT in Europe: strength and weakness of diverse independent screening trials.
    Silva M; Pastorino U; Sverzellati N
    Clin Radiol; 2017 May; 72(5):389-400. PubMed ID: 28168954
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lung Cancer Screening.
    Hoffman RM; Sanchez R
    Med Clin North Am; 2017 Jul; 101(4):769-785. PubMed ID: 28577626
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.